Microbot Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 1994
Net Income	-10.26	-10.74	-13.17	-11.31	-9.17	-7.25	Upgrade
Depreciation & Amortization	0.11	0.11	0.1	0.08	0.07	0.08	Upgrade
Share-Based Compensation	1.44	1.39	1.75	1.39	1.94	1.1	Upgrade
Other Operating Activities	0.96	0.71	-0.24	0.5	-0.09	-0.39	Upgrade
Operating Cash Flow	-7.75	-8.53	-11.55	-9.35	-7.25	-6.45	Upgrade
Capital Expenditures	-0.05	-0.03	-0.08	-0.07	-0.09	0.04	Upgrade
Change in Investments	-2.15	2.01	-3.75	3.27	-2.68	-2.5	Upgrade
Investing Cash Flow	-2.19	1.97	-3.84	3.2	-2.77	-2.45	Upgrade
Share Issuance / Repurchase	2.24	6.56	4.32	0	-3.38	36.77	Upgrade
Financing Cash Flow	2.24	6.56	4.32	0	-3.38	36.77	Upgrade
Net Cash Flow	-0.99	-0	-11.06	-6.15	-13.4	27.87	Upgrade
Free Cash Flow	-7.8	-8.57	-11.63	-9.42	-7.34	-6.41	Upgrade
Free Cash Flow Per Share	-0.56	-0.84	-1.60	-1.33	-1.03	-1.50	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).